Your browser doesn't support javascript.
loading
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.
Ganzel, Chezi; Sun, Zhuoxin; Cripe, Larry D; Fernandez, Hugo F; Douer, Dan; Rowe, Jacob M; Paietta, Elisabeth M; Ketterling, Rhett; O'Connell, Michael J; Wiernik, Peter H; Bennett, John M; Litzow, Mark R; Luger, Selina M; Lazarus, Hillard M; Tallman, Martin S.
Affiliation
  • Ganzel C; Shaare Zedek Medical Center, Jerusalem, Israel.
  • Sun Z; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.
  • Cripe LD; Indiana University Cancer Center, Indianapolis, Indiana.
  • Fernandez HF; H. Lee Moffitt Cancer Institute, Tampa, Florida.
  • Douer D; Memorial Sloan Kettering Cancer, New York, New York.
  • Rowe JM; Shaare Zedek Medical Center, Jerusalem, Israel.
  • Paietta EM; Rambam Medical Center, Haifa, Israel.
  • Ketterling R; Montefiore Medical Center, Bronx, New York.
  • O'Connell MJ; Mayo Clinic, Rochester, Minnesota.
  • Wiernik PH; Mayo Clinic, Rochester, Minnesota.
  • Bennett JM; Beth Israel Medical Center, New York, New York.
  • Litzow MR; University of Rochester Medical Center, Rochester, New York.
  • Luger SM; Mayo Clinic, Rochester, Minnesota.
  • Lazarus HM; University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tallman MS; Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, Ohio.
Am J Hematol ; 93(8): 1074-1081, 2018 Aug.
Article in En | MEDLINE | ID: mdl-29905379
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Hematol Year: 2018 Type: Article Affiliation country: Israel
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Hematol Year: 2018 Type: Article Affiliation country: Israel